Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh $94.38

up +0.20


16/9/2014 04:04 PM  |  NYSE : NVS  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get NVS Trend Analysis - it has outperformed the S&P 500 by 6%

Partner Headlines

  1. 3 Companies Investing In Stem Cell Research

    Benzinga
  2. Good news for Receptos drug

    IBD
  3. ReceptosMS Drug Yields More Good Data; Stock Jumps

    IBD
  4. ECB Decision Boosts ETFs

    Benzinga
  5. Novartis Drug Is Heartening

    IBD
  6. Novartis, Regeneron Cardio Results Pump Up Wall St.

    IBD
  7. Novartis, Regeneron Hit New Highs On Cardio Drugs

    IBD
  8. Benzinga's Volume Movers

    Benzinga
  9. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus
  10. Novartis: Ten Years of Solid ROE

    GuruFocus
  11. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  12. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  13. 5 New Medical Technologies For Diabetics

    Benzinga
  14. Novartis Joins Google To Develop Contacts For Diabetics

    Benzinga
  15. #PreMarket Primer: Friday, July 18: Tension Between Russia And The West ...

    Benzinga
  16. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga
  17. Earnings Scheduled For July 17, 2014

    Benzinga
  18. Google's X division

    IBD
  19. Benzinga Weekly Preview: Earnings Season Kicks Into High Gear

    Benzinga
  20. NOVARTIS

    IBD
  21. Novartis Announces Beginning of Shipment of Seasonal Influenza Vaccines ...

    Benzinga
  22. US Stock Futures Edge Higher Ahead Of Consumer Price Index

    Benzinga
  23. IPO Stock Watch: Receptos Soars On MS Drug Results

    IBD
  24. Joseph Papa, A Generic CEO With Brand-Name Action

    IBD
  25. ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects

    Benzinga
  26. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  27. Top Held European Stocks Highlighted by Health Care and Oil and Gas Stocks

    GuruFocus
  28. Two New WisdomTree International ETFs (IHDG, EUDG, BHP, NVS)

    Benzinga
  29. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  30. Can Pfizer Make Up Its Loss?

    GuruFocus
  31. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  32. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  33. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  34. China Rule Change Further Opens Yuan To World Markets

    IBD
  35. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus
  36. Drugmakers' Q1 was anemic

    IBD
  37. RBC Optimistic on Regeneron Following Lower Sales by Novartis' Lucentis

    Benzinga
  38. UPDATE: Novartis Posts Rise In Q1 Profit

    Benzinga
  39. Earnings Scheduled For April 24, 2014

    Benzinga
  40. Big Pharmas Swap Specialties

    IBD
  41. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  42. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  43. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  44. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  45. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  46. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  47. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  48. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  49. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  50. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
Trading Center